Pharma News

Genmab to acquire Merus shares for $8bn

Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN

Mytesi Seeks FDA Orphan Drug Designation in Breast Cancer Diarrhea

PILA PHARMA enters into agreement with the CRO GUBRA on preclinical trials of  XEN-D0501 in obesity

Pharma Tariffs Back In Spotlight On New Trump Threat

FDA approves Lilly’s Inluriyo to treat advanced breast cancer

Synaffix and Qurient enter licensing deal for dual-payload ADC

Biotech Stocks Facing FDA Decision In October 2025

WSU study first to determine best method of preclinical testing for alcohol use disorder medications

«Nightmare bacteria» cases on the rise in the US: CDC

NRx Pharmaceuticals Receives FDA Approval of Suitability Petition for Preservative-Free Ketamine Product

Akari Therapeutics’ Preclinical Data Demonstrates the Potential of its Novel ADC Spliceosome Modulating Payload, PH1